Teva Pharmaceutical Industries Ltd. — Earnings Release 2013

Aug 1, 2013

_________ false

C001��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: NYSE310379P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: tomer.amitai@teva.co.ilReported via MAGNA: 01/08/2013              Time of broadcast: 13:56 13:55:33

Reference: 2013-02-106515

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
TEVA REPORTS SECOND QUARTER 2013 RESULTS
Q213EarningsPRCombwtables_isa.pdf

Please find enclosed the above report and its non-binding Hebrew translation
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 26/06/2013
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 03-9267656 , Facsimile: 03-9148678 , E-mail: tomer.amitai@teva.co.il 2